Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis
Amy L Olson, Kevin K Brown, Jeffrey J SwigrisDepartment of Medicine Division of Pulmonary Medicine, Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Health, Denver, CO, USA Abstract: Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive pulmonary disease cha...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-05-01
|
| Series: | Patient Related Outcome Measures |
| Subjects: | |
| Online Access: | https://www.dovepress.com/understanding-and-optimizing-health-related-quality-of-life-and-physic-peer-reviewed-article-PROM |
| _version_ | 1819026338454962176 |
|---|---|
| author | Olson AL Brown KK Swigris JJ |
| author_facet | Olson AL Brown KK Swigris JJ |
| author_sort | Olson AL |
| collection | DOAJ |
| description | Amy L Olson, Kevin K Brown, Jeffrey J SwigrisDepartment of Medicine Division of Pulmonary Medicine, Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Health, Denver, CO, USA Abstract: Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive pulmonary disease characterized by the insidious onset of shortness of breath due to parenchymal scarring. As IPF progresses, breathlessness worsens, physical functional capacity declines, and health-related quality of life (HRQL) – the impact of health or disease on a person’s satisfaction with their overall station in life – deteriorates. These two inextricably linked variables – breathlessness and physical functional capacity – are strong drivers of HRQL. With the emergence of new and prospective therapies for IPF, it is more important than ever to be able to accurately and reliably assess how IPF patients feel and function. Doing so will promote the development of novel interventions to target impairments in these areas and ensure that the field is capable of assessing the effect of therapeutics interventions on these critically important patient-centered outcomes. Keywords: idiopathic pulmonary fibrosis, health-related quality of life, functional status |
| first_indexed | 2024-12-21T05:24:59Z |
| format | Article |
| id | doaj.art-5d19655a700647afb36dbb4c54c9f040 |
| institution | Directory Open Access Journal |
| issn | 1179-271X |
| language | English |
| last_indexed | 2024-12-21T05:24:59Z |
| publishDate | 2016-05-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Patient Related Outcome Measures |
| spelling | doaj.art-5d19655a700647afb36dbb4c54c9f0402022-12-21T19:14:43ZengDove Medical PressPatient Related Outcome Measures1179-271X2016-05-012016Issue 1293526963Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosisOlson ALBrown KKSwigris JJAmy L Olson, Kevin K Brown, Jeffrey J SwigrisDepartment of Medicine Division of Pulmonary Medicine, Interstitial Lung Disease Program and Autoimmune Lung Center, National Jewish Health, Denver, CO, USA Abstract: Idiopathic pulmonary fibrosis (IPF) is a relentlessly progressive pulmonary disease characterized by the insidious onset of shortness of breath due to parenchymal scarring. As IPF progresses, breathlessness worsens, physical functional capacity declines, and health-related quality of life (HRQL) – the impact of health or disease on a person’s satisfaction with their overall station in life – deteriorates. These two inextricably linked variables – breathlessness and physical functional capacity – are strong drivers of HRQL. With the emergence of new and prospective therapies for IPF, it is more important than ever to be able to accurately and reliably assess how IPF patients feel and function. Doing so will promote the development of novel interventions to target impairments in these areas and ensure that the field is capable of assessing the effect of therapeutics interventions on these critically important patient-centered outcomes. Keywords: idiopathic pulmonary fibrosis, health-related quality of life, functional status https://www.dovepress.com/understanding-and-optimizing-health-related-quality-of-life-and-physic-peer-reviewed-article-PROMIdiopathic Pulmonary FibrosisHealth-Related Quality of LifeFunctional Status |
| spellingShingle | Olson AL Brown KK Swigris JJ Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis Patient Related Outcome Measures Idiopathic Pulmonary Fibrosis Health-Related Quality of Life Functional Status |
| title | Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis |
| title_full | Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis |
| title_fullStr | Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis |
| title_full_unstemmed | Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis |
| title_short | Understanding and optimizing health-related quality of life and physical functional capacity in idiopathic pulmonary fibrosis |
| title_sort | understanding and optimizing health related quality of life and physical functional capacity in idiopathic pulmonary fibrosis |
| topic | Idiopathic Pulmonary Fibrosis Health-Related Quality of Life Functional Status |
| url | https://www.dovepress.com/understanding-and-optimizing-health-related-quality-of-life-and-physic-peer-reviewed-article-PROM |
| work_keys_str_mv | AT olsonal understandingandoptimizinghealthrelatedqualityoflifeandphysicalfunctionalcapacityinidiopathicpulmonaryfibrosis AT brownkk understandingandoptimizinghealthrelatedqualityoflifeandphysicalfunctionalcapacityinidiopathicpulmonaryfibrosis AT swigrisjj understandingandoptimizinghealthrelatedqualityoflifeandphysicalfunctionalcapacityinidiopathicpulmonaryfibrosis |